Interleukin-7
AssigneeImmunex Corporation
InventorsAnthony E. Namen, Raymond G. Goodwin, Stephen D. Lupton, Diane Y. Mochizuki
Life of this patent
Estimating the term…
Abstract
Mammalian Interleukin-7 proteins (IL-7s), DNAs and expression vectors encoding mammalian IL-7s, and processes for producing mammalian IL-7s as products of cell culture, including recombinant systems, are disclosed.
Claims4
Essentially homogeneous purified interleukin-7 (IL-7) wherein the purified IL-7 displays the ability to induce proliferation of bone marrow-derived pre-B cells;
- wherein a native glycosylated full length mature form of said IL-7 has a molecular weight of about 25,000 daltons as determined by SDS-PAGE;
- wherein the N-terminus of the mature form of the IL-7 protein comprises an amino acid sequence selected from Asp-Cys-Asp-Ile-Glu-Gly-Lys-Asp- and Glu-Cys-His-Ile-Lys-Asp-Lys-Glu.
Essentially homogeneous purified human IL-7 having the ability to induce proliferation of bone marrow-derived per-B cells, wherein said IL-7 comprises the amino acid sequence of residues 1-152 in FIG. 5.
A pharmaceutical composition comprising an effective amount of an essentially homogeneous purified human IL-7 in admixture with a suitable diluent or carrier, wherein said purified human IL-7 induces proliferation of bone marrow-derived pre-B cells;
- wherein a native glycosylated full length mature form of said IL-7 has a molecular weight of about 25,000 daltons as determined by SDS-PAGE;
- wherein the N-terminus of the mature form of the IL-7 protein comprises the amino acid sequence Asp-Cys-Asp-Ile-Glu-Gly-Lys-Asp-.
Dependencies are inferred from the claim text.